Recent Options for Phase 1 Formulation Development and Clinical Trial Material Supply - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Recent Options for Phase 1 Formulation Development and Clinical Trial Material Supply
To meet the demands of early-stage development, contract research organizations can evaluate various dosage-form options. The author examines various methods of capsule filling, including binary blends.


Pharmaceutical Technology


Conclusion

The methods of active pharmaceutical ingredient in a capsule, drug in a bottle, liquid in a capsule, or multiple binary blends provide options for getting drug product into the clinic in a short period of time. Although not all the options are capable of reaching commercial scale, they are all capable of supporting early clinical studies and may be used as a path to an eventual commercial dosage form.

Acknowledgment

The author is thankful to Paul Skultety, director of pharmaceutical development services at Xcelience for final review.

Balaji V. Kadri is a manager of the preformulation and formulation-development department at Xcelience, 5415 West Laurel St., Tampa, FL 33647, tel. 813.286.0404, fax 813.286.1105,

References

1. C.H. Dubin, "Formulation Strategies for Poorly Soluble Drugs," Drug Del. Technol. 6 (6), 34–38 (2006).

2. "Xcelodose S Precision Powder Mircodosing System," available at http://www.capsugel.com/pdf/xceloSBorchure.pdf, accessed July 17, 2008.

3. O.J. Murray, W. Dang, and D. Bergstrom, "Using an Electronic Tongue to Optimize Taste-Masking," Pharm. Technol., Outsourcing Resources suppl. 42–52 (Aug. 2004).

4. I. Alashkar, "It Tastes like Medicine," Pharma Quality 30–37 (Dec.–Jan., 2006).

5. M.E. Martelli, "Sublingual and Buccal Medication Administration," in Encyclopedia of Nursing and Allied Health (Thomson Gale, Farmington Hills, MI, 2008), pp. 1–9.

6. J.A. Nicollazzo and B.C. Finnin, "In Vivo and In Vitro Models for Assessing Drug Absorption Across the Buccal Mucosa," in Biotechnology: Pharmaceutical Aspects, vol. VII (Springer US, New York, 2007), pp. 89–111.

7. T.E. Cole, "Liquid Filled and Sealed Hard Gelatin Capsules," Capsugel Library (2000).

8. "Liquid Encapsulation Microspray Sealing (LEMS)," available at http://www.capsugel.com/equipment/cfs1200.php, accessed July 17, 2008.

9. Gattefossé. "Solubility and Bioavailability Enhancers," available at http://www.gattefosse.com/internet/gatt-wk3.nsf/TECHDOCPARCLEF/00000309?OpenDocument&Menu=1/, accessed June 19, 2008.

10. M. Richardson and S. Stegemann, "Filling Two-Piece Hard Gelatin Capsules with Liquids," Tablets & Capsules 3 (1), 97–110 (2006).


ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
25%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
59%
View Results
Jim MillerOutsourcing OutlookJim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
Rx-360 Takes on Europe, Talks to PharmTech in Podcast Series
Sanctions, Not Barcodes
Vaccines Finding Their Way in Novel Applications
Genzyme’s Friday the 13th
DTCA: Beneficial or Harmful?
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here